Trinity Biotech plc (TRIB) Tops Q3 EPS by 2c, Revenues Rose 6% Y/Y
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts TRIB Hot Sheet
Join SI Premium – FREE
Trinity Biotech plc (NASDAQ: TRIB) reported Q3 EPS of $0.18, $0.02 better than the analyst estimate of $0.16. Revenue for the quarter came in at $19.8 million versus the consensus estimate of $19.76 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
- Tompkins Financial (TMP) Tops Q3 EPS by 5c
- World Acceptance (WRLD) Tops Q2 EPS by 113c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
